Skip to main content
Premium Trial:

Request an Annual Quote

ABL, CRP-Santé Ink Software Licensing Agreement


Advanced Biological Laboratories has signed a commercial licensing agreement with the Public Research Center for Health (CRP-Santé), a Luxembourg-based biomedical research organization that allows it to include the latter's Context-based Modeling for Expeditious Typing (COMET) software, a tool for analyzing and classifying viral sequences, in its portfolio.

Chalom Sayada, CEO of ABL — which is also based in Luxembourg — said that his firm has already incorporated the software into DeepChek, its software for analyzing genomic data from HIV, hepatitis B virus, and HCV. "We are pleased …to have signed this exclusive commercial licensing agreement with CRP-Santé and to be able to promote COMET alone or embedded within ABL’s software applications," he said in a statement.

The financial terms of the agreement were not disclosed. COMET is still freely available for non-commercial research use.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.